Vichinsky E, Hoppe CC, Ataga KI, et al. Results from the randomized placebo-controlled phase 3 HOPE trial of voxelotor in adults and adolescents with sickle cell disease. 24th Congress of EHA, abstract S147.
Bij zeer kwetsbare premature baby’s beter te wachten met profylactische bloedtransfusies
dec 2019 | Benigne hematologie